T2	total-participants 643 646	144
T3	eligibility 647 675	healthy postmenopausal women
T8	age 1186 1190	59.4
T9	outcome 1321 1344	serum estrogens or SHBG
T10	outcome 1413 1431	Stratifying by BMI
T1	intervention 0 7	Aspirin
T5	control 1100 1114	placebo groups
T4	outcome 1554 1577	serum estrogens or SHBG
